Shares of Becton Dickinson Has Risen Above Previous 52-Week High
Becton Dickinson (NYSE:BDX) traded today at a new 52-week high of $166.34. This new high was reached on below average trading volume as 131,000 shares traded hands, while the average 30-day volume is approximately 885,000 shares.
Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company's products are used by health care professionals, medical research institutions, and the general public. Becton's products are marketed worldwide.
In the past 52 weeks, shares of Becton Dickinson have traded between a low of $128.87 and a high of $166.34 and are now at $166.25, which is 29% above that low price. The 200-day and 50-day moving averages have moved 0.19% higher and 0.83% higher over the past week, respectively.
Becton Dickinson (NYSE:BDX) is currently priced 1.2% above its average consensus analyst price target of $164.29. The stock should discover initial support at its 50-day moving average (MA) of $153.96 and subsequent support at its 200-day MA of $147.03.
SmarTrend recommended that subscribers consider buying shares of Becton Dickinson on February 17th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $143.14. Since that recommendation, shares of Becton Dickinson have risen 15.2%. We continue to monitor BDX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows becton dickinson